Whether a patient is in remission or currently undergoing treatment, the sooner cancer recurrence is discovered, the sooner the patient can receive appropriate treatments.
With OncoTracking™, signs of recurrence can be identified sooner than traditional screening tools. OncoTracking™ is a highly sensitive monitoring tool that utilizes liquid biopsy to screen for circulating tumor DNA (ctDNA), which is indicative of cancer recurrence and can be found before the recurrence is detectable on imaging.